Diabetes Technology

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

By

Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

By

The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.

Improved Glycemic Control With Closed-Loop Insulin Delivery System

Improved Glycemic Control With Closed-Loop Insulin Delivery System

By

Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

By

Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

By

In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

By

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

By

Participants completed surveys for fear of hypoglycemia, hypoglycemia unawareness, and problem areas in diabetes questionnaire.

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

By

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

First CGM System With Implantable Glucose Sensor Approved

First CGM System With Implantable Glucose Sensor Approved

By

The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.

FDA Clears Omnipod DASH System for Diabetes Management

FDA Clears Omnipod DASH System for Diabetes Management

By

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

By

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

By

Interpreting trend arrow data from continuous glucose monitoring may provide additional data to improve glycemic control in adults with diabetes mellitus.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

By

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

By

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Machines were used to examine the glycemic impact of various meals to determine a glucose forecast.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

By

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

By

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

By

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

By

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

By

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

By

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

By

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Blood Glucose Meter Accuracy Called Into Question

Blood Glucose Meter Accuracy Called Into Question

The paper raises questions regarding safety for measuring blood glucose, and when blood glucose meters are used in trials.

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

By

The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring system for patients with diabetes.

Roche Launches First Glucose Meter With Insulin Calculator

Roche Launches First Glucose Meter With Insulin Calculator

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

Sign Up for Free e-Newsletters



CME Focus